Literature DB >> 22273848

Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma.

Dan He1, Quan Zeng, Guosheng Ren, Tingxiu Xiang, Yi Qian, Qin Hu, Jiang Zhu, Suling Hong, Guohua Hu.   

Abstract

Protocadherin8 (PCDH8), an integral membrane protein, was reported to be a tumor suppressor involved in tumorigenesis in cancers. We aimed to investigate the epigenetic inactivation of PCDH8 and its tumor-suppressor function in nasopharyngeal carcinoma (NPC). Frequent downregulation/silencing of PCDH8 was found in NPC cell lines using semiquantitative PCR. Promoter methylation of PCDH8 was observed in 100% (5/5) of cell lines and 85.3% (35/41) of primary tumors by methylation-specific PCR, but not in normal nasopharyngeal tissues. Treatment of NPC cells with 5-aza-2'-deoxycytidine and/or trichostatin A could restore PCDH8 expression. Ectopic expression of PCDH8 in silenced NPC cells significantly inhibited cell colony formation and cell migration. For the first time, our study demonstrates the epigenetic inactivation of PCDH8 by promoter methylation and its tumor-suppressive function in NPC. Thus, PCDH8 could be identified as a tumor suppressor in NPC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22273848     DOI: 10.1097/CEJ.0b013e328350b097

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  17 in total

1.  miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Authors:  Jianfei Xue; Aidong Zhou; Yamei Wu; Saint-Aaron Morris; Kangyu Lin; Samirkumar Amin; Roeland Verhaak; Gregory Fuller; Keping Xie; Amy B Heimberger; Suyun Huang
Journal:  Cancer Res       Date:  2016-05-31       Impact factor: 12.701

Review 2.  Beyond E-cadherin: roles of other cadherin superfamily members in cancer.

Authors:  Frans van Roy
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

3.  Aberrant methylation of PCDH8 is a potential prognostic biomarker for patients with clear cell renal cell carcinoma.

Authors:  Ying-Li Lin; Yan-Ling Wang; Xing-Li Fu; Jian-Guo Ma
Journal:  Med Sci Monit       Date:  2014-11-22

4.  Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.

Authors:  Ying-Li Lin; Yan-Ling Wang; Jian-Guo Ma; Wen-Ping Li
Journal:  J Exp Clin Cancer Res       Date:  2014-08-22

5.  PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance.

Authors:  Cheng Zhang; Yunfei Peng; Fan Yang; Ruixi Qin; Wenjun Liu; Cuijuan Zhang
Journal:  J Cancer       Date:  2016-01-29       Impact factor: 4.207

6.  Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.

Authors:  Yuan Cao; Yan Yu; Xiaolong Chen; Fang Ren; Ruitao Zhang; Yanyan Jia; Zhigang Ren; Ranran Sun; Juan Li; Huirong Shi
Journal:  Int J Gynecol Cancer       Date:  2018-02       Impact factor: 3.437

7.  PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3β/β-catenin signaling pathway.

Authors:  Zhenkun Zong; Hui Pang; Rutong Yu; Yunqi Jiao
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

8.  Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.

Authors:  Ying-Li Lin; Pei-Gen Xie; Li Wang; Jian-Guo Ma
Journal:  Med Sci Monit       Date:  2014-08-05

9.  Promoter methylation of protocadherin8 is an independent prognostic factor for biochemical recurrence of early-stage prostate cancer.

Authors:  Wen-Bin Niu; Shi-Liang Gui; Ying-Li Lin; Xing-Li Fu; Jian-Guo Ma; Wen-Ping Li
Journal:  Med Sci Monit       Date:  2014-12-08

10.  Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling.

Authors:  Lian Hui; Jingru Zhang; Xiaoxu Ding; Xing Guo; Xuejun Jang
Journal:  Oncol Lett       Date:  2017-09-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.